![]() |
市場調查報告書
商品編碼
1957279
RNAi農藥市場-全球產業規模、佔有率、趨勢、機會與預測:按應用、作物類型、產品、地區和競爭格局分類,2021-2031年RNAi Pesticides Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Crop Type, By Product, By Region & Competition, 2021-2031F |
||||||
全球 RNAi 殺蟲劑市場預計將從 2025 年的 17.2 億美元成長到 2031 年的 30.4 億美元,複合年成長率為 9.96%。
這些殺蟲劑利用雙鏈RNA序列誘導目標害蟲基因靜默,從而抑制必需蛋白質的合成,最終殺死害蟲,且不會傷害非目標生物。市場成長主要受全球對無殘留農產品需求不斷成長以及害蟲對傳統化學殺蟲劑抗藥性日益增強的驅動。此外,支持性法規結構加快了生物作物保護劑的核准,為產業發展奠定了堅實的基礎,使其超越了短暫的流行趨勢。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 17.2億美元 |
| 市場規模:2031年 | 30.4億美元 |
| 複合年成長率:2026-2031年 | 9.96% |
| 成長最快的細分市場 | 農業用途 |
| 最大的市場 | 北美洲 |
儘管該領域潛力巨大,但仍面臨許多挑戰,包括雙鏈RNA的高昂生產成本及其在環境條件下的快速分解,這些都限制了其實際應用。然而,近期行業統計數據顯示,商業性商業性日益增強。
害蟲對傳統化學農藥的抗藥性日益增強,是全球RNAi農藥市場的主要驅動力。隨著目標生物對現有合成化合物產生免疫力,農業部門正面臨產量穩定性下降和病蟲害控制成本飆升的雙重困境,因此迫切需要新的作用機制,例如能夠使特定基因惰性的RNA干擾。這種經濟壓力十分嚴峻,凸顯了對有效生物替代療法的迫切需求。根據《馬鈴薯商業》雜誌2024年1月報道,化學農藥抗藥性問題的蔓延預計每年將給美國農業部門造成至少100億美元的損失,生產者正在尋求既能規避這些抗藥性機制又能保護環境的解決方案。
同時,RNAi遞送技術和製劑穩定性的技術突破正在有效克服與田間永續性和生產成本相關的傳統挑戰。近期創新使得將雙鏈RNA封裝在穩健的載體中成為可能,從而確保其在各種環境條件下均能有效發揮作用,並獲得監管部門的核准。例如,根據GreenLight Biosciences公司2024年1月發布的公告,其新註冊的生物農藥Calantha的田間試驗表明,僅需每英畝4克的低施用量即可有效控制害蟲。這種精準度反映了該行業在開發高度穩定、可直接用於田間試驗的產品方面取得的進展,並吸引了更多投資。作為這種投資動能的例證,AgroSpheres公司於2024年9月獲得了3,700萬美元的B輪資金籌措,以擴大其專有的生物製造和遞送平台。
雙鏈RNA(dsRNA)的高生產成本及其在環境中的快速分解,嚴重阻礙了全球RNAi農藥市場的商業性化規模化。這些特殊RNA序列的生產需要複雜的發酵或化學合成工藝,其高成本遠高於傳統農藥,使得最終產品在許多低利潤主糧作物上難以應用。這種價格差距限制了該技術的競爭力,迫使生產者專注於高價值的細分市場,而非大規模農業生產。
此外,裸露的雙股RNA本身穩定性較差,且易受紫外線和雨水侵蝕而迅速分解,因此開發先進的包封技術至關重要。這項要求進一步增加了技術複雜性和研發成本,延緩了產品上市。根據國際作物生命聯盟(CropLife International)預測,到2024年,發現、開發和註冊一種新的作物保護活性成分的平均成本將達到3.01億美元,研發週期超過12年。如此龐大的資金和時間投入提高了進入門檻,阻礙了中小型生技公司的投資,並減緩了RNAi領域產品商業化的整體步伐。
噴灑型和施用型RNAi生物農藥的商業化進程正迅速從田間試驗階段邁向市場滲透階段,這主要得益於旨在擴大產能的大規模後期融資。隨著技術的日益成熟,越來越多的公司正在籌集必要的資金,以擴大葉面噴布解決方案的產能,從而實現無殘留病蟲害防治。例如,GreenLight Biosciences於2025年3月完成了由Just Climate主導的2500萬美元C資金籌措,用於支援其已註冊的RNA農作物保護產品的商業化部署。這凸顯了該產業正從研發階段轉向商業化執行階段的轉變。
同時,大型農藥公司與生技新興企業之間的策略合作正在重塑競爭格局。透過將新興企業的基因靜默技術與成熟企業的全球分銷網路相結合,跨國公司可以迅速將尖端的基因編輯技術和RNAi特性整合到其產品組合中,而中小型創新企業則能夠進入廣闊的國際市場。例如,先正達蔬菜種子有限公司於2025年5月宣布將與Tropic公司合作,將其基因編輯誘導基因靜默(GEiGS)技術推廣到全球90多個國家。這正是利用成熟農藥生產商龐大的商業性網路加速精準生物性狀應用的一種共生經營模式的典範。
The Global RNAi Pesticides Market is projected to expand from USD 1.72 Billion in 2025 to USD 3.04 Billion by 2031, registering a compound annual growth rate of 9.96%. These pesticides function by utilizing double-stranded RNA sequences to induce gene silencing in targeted pests, thereby inhibiting essential protein synthesis and causing mortality without harming non-target organisms. The market is largely propelled by the critical global requirement for agricultural produce free of residues and the mounting resistance of pests to traditional chemical synthetics. Additionally, supportive regulatory frameworks that expedite the approval of biological crop protection agents provide a solid foundation for industry expansion, distinguishing it from temporary adoption trends.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.72 Billion |
| Market Size 2031 | USD 3.04 Billion |
| CAGR 2026-2031 | 9.96% |
| Fastest Growing Segment | Agricultural Application |
| Largest Market | North America |
Despite this potential, the sector encounters a significant hurdle regarding the high expense of double-stranded RNA production and its rapid degradation in environmental conditions, which complicates field application. However, commercial confidence in the broader sector remains robust, as reflected in recent industry statistics. Data from the International Biocontrol Manufacturers Association indicates that in 2024, the European biocontrol market reached a value of 1.6 billion euros following a doubling of the sector size since 2016. This substantial growth in the parent industry highlights the increasing commercial feasibility of biological alternatives such as RNAi.
Market Driver
The escalating resistance of pests to conventional chemical pesticides serves as the primary catalyst driving the Global RNAi Pesticides Market. As target organisms develop immunity to existing synthetic compounds, the agricultural sector confronts diminishing yield security and spiraling control costs, creating an urgent imperative for novel modes of action like RNA interference that can silence specific genes. This economic pressure is severe and underscores the financial necessity for effective biological alternatives; according to Potato Business in January 2024, the growing issue of chemical pesticide resistance is predicted to cost the United States agricultural sector at least USD 10 billion annually, prompting growers to seek solutions that bypass these resistance mechanisms while preserving environmental integrity.
Simultaneously, technological breakthroughs in RNAi delivery and formulation stability are effectively dismantling historical barriers related to field persistence and production costs. Recent innovations have enabled the encapsulation of double-stranded RNA in robust carriers, ensuring efficacy in diverse environmental conditions and securing regulatory validation. For instance, according to GreenLight Biosciences in January 2024, field trials for its newly registered Calantha bioinsecticide demonstrated effective pest control with application rates as low as 4 grams per acre. Such precision demonstrates the sector's progress in creating stable, field-ready products, which is further attracting significant capital; illustrating this investment momentum, AgroSpheres secured $37 million in Series B funding in September 2024 to scale its proprietary biomanufacturing and delivery platform.
Market Challenge
The high cost of double-stranded RNA (dsRNA) production combined with its rapid environmental degradation constitutes a severe impediment to the commercial scalability of the Global RNAi Pesticides Market. Manufacturing these specialized RNA sequences involves complex fermentation or chemical synthesis processes that remain significantly more expensive than conventional agrochemicals, making the final product economically unfeasible for many low-margin staple crops. This price disparity limits the technology's competitiveness, forcing manufacturers to restrict their focus to high-value niche markets rather than broad-acre agriculture.
Furthermore, the inherent instability of naked dsRNA, which breaks down quickly under UV light and rain, necessitates the development of sophisticated encapsulation technologies. This requirement adds layers of technical complexity and developmental expense, further delaying market entry. According to CropLife International, in 2024, the average cost to discover, develop, and register a new crop protection active ingredient reached $301 million, with a development timeline extending over 12 years. These immense capital and time requirements create high barriers to entry, discouraging investment from smaller biotech firms and slowing the overall rate of product commercialization within the RNAi sector.
Market Trends
The commercialization of sprayable and topical RNAi biopesticides is rapidly transitioning from experimental field trials to active market penetration, supported by substantial late-stage capital injections aimed at scaling manufacturing capabilities. As the technology matures, companies are securing the necessary financial resources to expand production capacities for foliar-applied solutions that offer residue-free pest control. Illustrating this push toward mass-market availability, according to GreenLight Biosciences in March 2025, the company closed a $25 million Series C funding round led by Just Climate to support the commercial rollout of its registered RNA-based crop protection products, highlighting the industry's shift from discovery to commercial execution.
Strategic collaborations between agrochemical giants and biotech startups are simultaneously reshaping the competitive landscape by combining the specialized gene-silencing platforms of emerging firms with the global distribution networks of established incumbents. These partnerships allow large multinationals to rapidly integrate cutting-edge gene-editing and RNAi traits into their portfolios while providing smaller innovators access to vast international markets. For instance, according to Syngenta Vegetable Seeds in May 2025, the company entered a collaboration with Tropic to deploy the Gene Editing induced Gene Silencing (GEiGS) technology across its global footprint, which spans more than 90 countries, underscoring a symbiotic business model where the immense commercial reach of legacy agrochemical players is leveraged to accelerate the deployment of precise biological traits.
Report Scope
In this report, the Global RNAi Pesticides Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global RNAi Pesticides Market.
Global RNAi Pesticides Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: